Home - Clinical Trials Arena
Lead Gilead researcher highlights need for inclusive clinical trials for HIV. Considering “health equity aspects”, Moupali Das highlighted the historic underrepresentation of disproportionately affected communities.
News - Clinical Trials Arena
Sections. Company A-Z; Company Categories; Products & Services; Company Releases; White Papers; Videos; Buyer's Guides; Partner Content; Latest. Leading sales enablement, prospecting and automation providers and technology solutions for the clinical trials industry
Features - Clinical Trials Arena
Prostate cancer: Three drug trials to watch. Today (19 November) marks International Men’s Day with the theme for 2024 being Men's Health Champions, shining a light on…
Analysis - Clinical Trials Arena
Sections. Company A-Z; Company Categories; Products & Services; Company Releases; White Papers; Videos; Buyer's Guides; Partner Content; Latest. Leading sales enablement, prospecting and automation providers and technology solutions for the clinical trials industry
Phase 0 clinical trials: what you need to know
Jul 21, 2022 · 2021 was a record-breaking year, with more businesses breaking into the billion-dollar club. Many start-ups have achieved or retained the unicorn status by the end of the year to reflect nearly a fivefold growth from that in 2020.
Obesity: Six trials to watch over the next 12 months
Jun 30, 2023 · With an estimated market value of $37.1bn in 2031, the race for the development of obesity medications is on. Here are some trials to watch.
Sorrento Enrolls 60 of 80 Patients for Phase II Trial of Abivertinib in ...
Feb 11, 2021 · Implications for Phase II Trial Abivertinib’s. Sorrento Therapeutics’ Phase II study of the tyrosine kinase inhibitor (TKI) STI-5656 (abivertinib) in hospitalised Covid-19 patients has enrolled 60 of its 80-patient target, said CEO Henry Ji.A futility analysis is planned with 40 patients who have already been enrolled, he said.
BioNTech treats first subject in Phase II cancer vaccine trial
Oct 20, 2023 · BioNTech is co-developing the vaccine candidate along with Roche unit Genentech. The vaccine encodes for up to 20 cancer mutations that are specific to patients.
DCT Tracker: tracing industry’s adoption of decentralised clinical …
Since early 2022, this news service has tracked the adoption of DCTs and observed the rise and fall in popularity in certain elements central to the decentralisation approach. Using data from GlobalData’s Clinical Trial Database, this news service tracked the numbers of initiated clinical trials employing specific DCT methods or tools each year.
Trials to watch: CRISPR pipeline accelerates after milestone …
Jan 17, 2024 · December 2023 marked an important milestone in the life of clustered regularly interspaced short palindromic repeat (CRISPR) therapies after Vertex Pharmaceuticals and CRISPR Therapeutics exagamglogene autotemcel received approval from the US Food and Drug Administration (FDA), following a nod from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) a month earlier.